{"transactions":[{"id":4371473,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":177478,"kind":"person","name":"Tajak Richard J.","position":1,"cik":"0001434575","reported_name":"Tajak Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2017-03-27T13:12:59.000Z","date":"2017-03-23","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units (\"RSUs\") will vest as follows: 1/4th of the RSUs subject to the award shall vest 3 months following the vesting commencement date on the same day of the month as the vesting commencement date, and 1/4th of the RSUs subject to the award shall vest every 3 months thereafter on the same day of the month as the vesting commencement date such that the award shall be fully vested on March 23, 2017.  The vesting commencement date for this award is March 23, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units (\"RSUs\") will vest as follows: 1/4th of the RSUs subject to the award shall vest 3 months following the vesting commencement date on the same day of the month as the vesting commencement date, and 1/4th of the RSUs subject to the award shall vest every 3 months thereafter on the same day of the month as the vesting commencement date such that the award shall be fully vested on March 23, 2017.  The vesting commencement date for this award is March 23, 2016."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-17-022924","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434575/000120919117022924/doc4.xml","form_type":"4"}},{"id":4371472,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":177478,"kind":"person","name":"Tajak Richard J.","position":1,"cik":"0001434575","reported_name":"Tajak Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-27T13:12:59.000Z","date":"2017-03-23","kind":"tax_withholding","acquired":false,"shares":1983,"price":3.43,"value":6801.69,"ownership":{"direct":true},"balance_after":12876,"source":{"system":"sec-edgar","filing":"0001209191-17-022924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434575/000120919117022924/doc4.xml","form_type":"4"}},{"id":4371471,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":177478,"kind":"person","name":"Tajak Richard J.","position":1,"cik":"0001434575","reported_name":"Tajak Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-27T13:12:59.000Z","date":"2017-03-23","kind":"exercise","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."}],"balance_after":14859,"source":{"system":"sec-edgar","filing":"0001209191-17-022924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434575/000120919117022924/doc4.xml","form_type":"4"}},{"id":4511265,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":177478,"kind":"person","name":"Tajak Richard J.","position":1,"cik":"0001434575","reported_name":"Tajak Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-28T19:04:32.000Z","date":"2016-12-23","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units (\"RSUs\") will vest as follows: 1/4th of the RSUs subject to the award shall vest 3 months following the vesting commencement date on the same day of the month as the vesting commencement date, and 1/4th of the RSUs subject to the award shall vest every 3 months thereafter on the same day of the month as the vesting commencement date such that the award shall be fully vested on March 23, 2017.  The vesting commencement date for this award is March 23, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units (\"RSUs\") will vest as follows: 1/4th of the RSUs subject to the award shall vest 3 months following the vesting commencement date on the same day of the month as the vesting commencement date, and 1/4th of the RSUs subject to the award shall vest every 3 months thereafter on the same day of the month as the vesting commencement date such that the award shall be fully vested on March 23, 2017.  The vesting commencement date for this award is March 23, 2016."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-16-156930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434575/000120919116156930/doc4.xml","form_type":"4"}},{"id":4511264,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":177478,"kind":"person","name":"Tajak Richard J.","position":1,"cik":"0001434575","reported_name":"Tajak Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-12-28T19:04:32.000Z","date":"2016-12-23","kind":"tax_withholding","acquired":false,"shares":1717,"price":6.15,"value":10559.55,"ownership":{"direct":true},"balance_after":9858,"source":{"system":"sec-edgar","filing":"0001209191-16-156930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434575/000120919116156930/doc4.xml","form_type":"4"}},{"id":4511263,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":177478,"kind":"person","name":"Tajak Richard J.","position":1,"cik":"0001434575","reported_name":"Tajak Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-12-28T19:04:32.000Z","date":"2016-12-23","kind":"exercise","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."}],"balance_after":11575,"source":{"system":"sec-edgar","filing":"0001209191-16-156930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434575/000120919116156930/doc4.xml","form_type":"4"}},{"id":4594182,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":177478,"kind":"person","name":"Tajak Richard J.","position":1,"cik":"0001434575","reported_name":"Tajak Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2016-09-27T19:37:12.000Z","date":"2016-09-23","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units (\"RSUs\") will vest as follows: 1/4th of the RSUs subject to the award shall vest 3 months following the vesting commencement date on the same day of the month as the vesting commencement date, and 1/4th of the RSUs subject to the award shall vest every 3 months thereafter on the same day of the month as the vesting commencement date such that the award shall be fully vested on March 23, 2017.  The vesting commencement date for this award is March 23, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units (\"RSUs\") will vest as follows: 1/4th of the RSUs subject to the award shall vest 3 months following the vesting commencement date on the same day of the month as the vesting commencement date, and 1/4th of the RSUs subject to the award shall vest every 3 months thereafter on the same day of the month as the vesting commencement date such that the award shall be fully vested on March 23, 2017.  The vesting commencement date for this award is March 23, 2016."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-16-142963","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434575/000120919116142963/doc4.xml","form_type":"4"}},{"id":4594181,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":177478,"kind":"person","name":"Tajak Richard J.","position":1,"cik":"0001434575","reported_name":"Tajak Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-09-27T19:37:12.000Z","date":"2016-09-23","kind":"tax_withholding","acquired":false,"shares":1717,"price":7.91,"value":13581.47,"ownership":{"direct":true},"balance_after":6575,"source":{"system":"sec-edgar","filing":"0001209191-16-142963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434575/000120919116142963/doc4.xml","form_type":"4"}},{"id":4594180,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":177478,"kind":"person","name":"Tajak Richard J.","position":1,"cik":"0001434575","reported_name":"Tajak Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-09-27T19:37:12.000Z","date":"2016-09-23","kind":"exercise","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."}],"balance_after":8292,"source":{"system":"sec-edgar","filing":"0001209191-16-142963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434575/000120919116142963/doc4.xml","form_type":"4"}}]}